Cited by 16Endometriosis Research and TreatmentAdipokines, Inflammation, and Metabolic DiseasesCancer Risks and Factors

Plasma adipokines and endometriosis risk: a prospective nested case-control investigation from the Nurses' Health Study II

Open access
Shah, D. K., Correia, K. F., Harris, H. R., Missmer, S. A.·2013·Human Reproduction

Abstract

STUDY QUESTION: Do higher leptin levels and lower adiponectin levels predict subsequent development of endometriosis? SUMMARY ANSWER: Plasma leptin and adiponectin levels were not associated with laparoscopically confirmed endometriosis when collected prior to disease diagnosis. WHAT IS KNOWN ALREADY: Case-control studies have identified altered levels of the inflammatory adipokines leptin and adiponectin in women with endometriosis, but it remains unclear whether inflammation results in endometriosis or whether the presence of endometriosis creates an inflammatory state. STUDY DESIGN, SIZE, DURATION: Nested, matched, case-control study within the prospective Nurses' Health Study II (NHS II) cohort. Blood samples were collected between 1996 and 1999 from 29 611 female nurses within the cohort. Women who reported endometriosis before blood collection were excluded. PARTICIPANTS/MATERIALS, SETTING, METHODS: Plasma leptin and adiponectin levels were assayed by ELISA. Three hundred and fifty cases of laparoscopically confirmed endometriosis were matched 1:2 with 694 controls of comparable race, age, infertility history, menopausal status and time of blood draw. Relative risks (RRs) and 95% confidence intervals (CIs) were calculated using unconditional logistic regression models adjusting for matching factors and BMI. MAIN RESULTS AND THE ROLE OF CHANCE: After adjusting for BMI, there were no statistically significant associations between endometriosis and leptin [RR = 1.2; 95% CI = 0.7-2.0; P-value, test for linear trend (P(trend)) = 0.72], adiponectin (RR = 0.8; 95% CI = 0.5-1.2; P(trend) = 0.48) or the leptin to adiponectin ratio (RR = 0.8; 95% CI = 0.4-1.4; P(trend) = 0.14) when comparing the upper with the lower quartile. Results were unaltered when analyses were stratified by BMI or restricted to cases diagnosed ≥ 4 years after blood draw. To evaluate statistical significance and limit the role of chance to the gold standard of 5%, we present 95% CIs about the RRs, and for P-values calculated for linear tests of trend and tests of heterogeneity, we have set the α-level to be 0.05 (i.e. <0.05 is considered to be statistically significant). LIMITATIONS AND REASONS FOR CAUTION: A limitation of this study is the inability to differentiate the time of endometriosis 'diagnosis' from the time of disease 'onset' due to the impossibility in identifying a precise time point at which the disease process was first initiated at a molecular or cellular level. Additional limitations include lack of information regarding stage of endometriosis and the possibility of asymptomatic disease in the control population. WIDER IMPLICATIONS OF THE FINDINGS: The mean age at diagnosis of endometriosis in the study population is 41.7, ≈ 10 years older than the mean age of diagnosis in the general population. While this may limit the generalizability of the results, there is no reason to suspect that the association between adipokines and endometriosis risk should differ at a younger age of diagnosis in an adult population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/des411

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Contrasting evidence exists on prolactin, leptin, LH, and adiponectin levels in endometriosis patients versus controls, showing either no difference, an increase (prolactin, leptin, LH) or a decrease (adiponectin).

    “Contrasting evidence exists on prolactin, leptin, luteinizing hormone (LH), and adiponectin levels in endometriosis patients versus controls, showing either no difference, an increase (prolactin, leptin LH) or a decrease (adiponectin) [23, 75, 76].”

    From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [75]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shah, D. K., Correia, K. F., Harris, H. R., & Missmer, S. A.
Affiliations
  • University of Iowa (US)
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
Shah, D. K.
Venue
Human Reproduction
Published
2012-11-27
Volume
28
Issue
2
Pages
315-321
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2116424293
Cited by
16
References
35
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 5 · 2015: 1 · 2014: 1
FWCI
0.74
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service (5T76MC00001)
  • National Cancer Institute (CA50385, R01CA050385)
  • National Institute of Environmental Health Sciences (T32ES007069)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD52473, R01HD057210, HD48544, R01HD052473, R03HD048544, HD57210)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
endometriosis, leptin, adiponectin, adipokines, plasma biomarkers, endometriosis risk, leptin/adiponectin ratio, inflammation, Nurses' Health Study II, premenopausal women, body mass index
MeSH terms
Adult, Endometriosis, Female, Humans, Middle Aged, Prospective Studies, Risk Factors, Case-Control Studies, Leptin, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review